Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_assertion type Assertion NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_head.
- NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_assertion description "[MAL methylation status may therefore serve as a marker of platinum sensitivity while MAL protein may be a target for development of novel therapies aimed at enhancing sensitivity to platinum-based drugs in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_provenance.
- NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_assertion evidence source_evidence_literature NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_provenance.
- NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_assertion SIO_000772 19642140 NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_provenance.
- NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_assertion wasDerivedFrom befree-2016 NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_provenance.
- NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_assertion wasGeneratedBy ECO_0000203 NP754397.RA2Uizi-enoFmuOizNZV9Vrr3OU0GtiuhoWEgB6mSFfeQ130_provenance.